Skip to main content

Table 2 MIC breakpoints and in vitro susceptibility of Mycobacterium avium complex

From: Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease

 

MIC (μg/ml)

Antibiotics

≦0.125

0.25

0.5

1

2

4

8

16

32

64

≧128

RFP

9

3

9

3

4

3

1

1

   

EB

    

1

 

5

12

5

8

2

LVFX

 

2

13

6

7

2

2

1

   

KM

   

2

2

10

9

3

1

0

6

SM

  

1

3

9

10

9

1

   

AMK

   

2

2

9

9

3

8

  
  1. MIC minimum inhibitory concentration, RFP rifampicin, EB ethambutol, LVFX levofloxacin, KM kanamycin, SM streptomycin, AMK amikacin
  2. Italics and bold type indicate susceptible and resistant categories of interpretive criteria for each antimicrobial agent, respectively
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us